Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

Combinations of dacarbazine (DTIC) and other cytotoxic agents or alpha-interferon were given to 136 patients in five different regimens. The total response rate was 32% (95% confidence interval 24-40%); 13% had a complete remission. Female patients had a significantly higher chance of response than...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033382/
https://www.ncbi.nlm.nih.gov/pubmed/7522510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033382/
https://www.ncbi.nlm.nih.gov/pubmed/7522510

Ejemplares similares